Worldquant Millennium Advisors LLC Incyte Corp Transaction History

Worldquant Millennium Advisors LLC

$13.6 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$51.18 - $63.75 $7.78 Million - $9.69 Million	-152,020 Reduced 27.14%	408,051 $24.7 Million
Q1 2024 May 15, 2024	SELL	$56.55 - $66.59 $24.6 Million - $28.9 Million	-434,445 Reduced 43.68%	560,071 $31.9 Million
Q4 2023 Feb 14, 2024	BUY	$52.16 - $64.19 $14 Million - $17.2 Million	268,453 Added 36.97%	994,516 $62.4 Million
Q3 2023 Nov 14, 2023	BUY	$57.77 - $65.93 $20.1 Million - $22.9 Million	347,123 Added 91.6%	726,063 $41.9 Million
Q2 2023 Aug 14, 2023	BUY	$60.95 - $75.51 $10.7 Million - $13.3 Million	175,776 Added 86.52%	378,940 $23.6 Million
Q1 2023 May 15, 2023	BUY	$70.23 - $86.01 $8.67 Million - $10.6 Million	123,476 Added 154.95%	203,164 $14.7 Million
Q4 2022 Feb 14, 2023	SELL	$67.18 - $84.11 $3.35 Million - $4.19 Million	-49,837 Reduced 38.48%	79,688 $6.4 Million
Q3 2022 Nov 14, 2022	SELL	$66.18 - $82.86 $438,310 - $548,781	-6,623 Reduced 4.86%	129,525 $8.63 Million
Q2 2022 Aug 15, 2022	BUY	$66.18 - $83.18 $3.33 Million - $4.19 Million	50,376 Added 58.73%	136,148 $10.3 Million
Q1 2022 May 16, 2022	SELL	$66.02 - $79.71 $13.6 Million - $16.4 Million	-205,377 Reduced 70.54%	85,772 $6.81 Million
Q4 2021 Feb 14, 2022	BUY	$63.34 - $74.11 $10.5 Million - $12.3 Million	165,623 Added 131.94%	291,149 $21.4 Million
Q3 2021 Nov 15, 2021	SELL	$68.67 - $84.02 $3.25 Million - $3.97 Million	-47,265 Reduced 27.35%	125,526 $8.63 Million
Q2 2021 Aug 16, 2021	SELL	$79.87 - $87.53 $1.87 Million - $2.05 Million	-23,398 Reduced 11.93%	172,791 $14.5 Million
Q3 2020 Nov 16, 2020	BUY	$85.07 - $109.69 $160,016 - $206,326	1,881 Added 0.97%	196,189 $17.6 Million
Q2 2020 Aug 14, 2020	SELL	$74.18 - $108.93 $13.7 Million - $20.1 Million	-184,842 Reduced 48.75%	194,308 $20.2 Million
Q1 2020 May 14, 2020	SELL	$63.18 - $85.97 $785,516 - $1.07 Million	-12,433 Reduced 3.18%	379,150 $27.8 Million
Q4 2019 Feb 14, 2020	SELL	$73.04 - $95.72 $3.43 Million - $4.5 Million	-47,025 Reduced 10.72%	391,583 $34.2 Million
Q3 2019 Nov 14, 2019	SELL	$72.82 - $86.52 $3.41 Million - $4.05 Million	-46,827 Reduced 9.65%	438,608 $32.6 Million
Q2 2019 Aug 14, 2019	BUY	$73.52 - $88.7 $4.6 Million - $5.55 Million	62,616 Added 14.81%	485,435 $41.2 Million
Q1 2019 May 14, 2019	BUY	$63.56 - $88.17 $1.21 Million - $1.68 Million	19,047 Added 4.72%	422,819 $36.4 Million
Q4 2018 Feb 14, 2019	BUY	$58.5 - $69.94 $3.46 Million - $4.14 Million	59,127 Added 17.16%	403,772 $25.7 Million
Q3 2018 Nov 14, 2018	BUY	$61.75 - $74.23 $18.8 Million - $22.6 Million	304,424 Added 756.88%	344,645 $23.8 Million
Q2 2018 Aug 14, 2018	BUY	$60.85 - $83.98 $2.45 Million - $3.38 Million	40,221 New	40,221 $2.7 Million

Others Institutions Holding INCY

# of Institutions

642

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15.8B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Worldquant Millennium Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Worldquant Millennium Advisors LLC with notifications on news.

Account